The role of metabolism and specific metabolites in benzene-induced toxicity: Evidence and issues

Journal of Toxicology and Environmental Health - Part A

Volumn 61, Issue 5-6, 2000, Pages 357-372

  Ross, David ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; MUCONALDEHYDE; MUCONIC ACID; PHENOL DERIVATIVE; QUINONE DERIVATIVE;

ACUTE MYELOBLASTIC LEUKEMIA; APLASTIC ANEMIA; CONFERENCE PAPER; DISEASE PREDISPOSITION; EXPERIMENTAL MODEL; HUMAN; LEUKEMOGENESIS; LONG TERM EXPOSURE; METABOLISM; METABOLITE; MYELODYSPLASTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BENZENE; HUMANS;

EID: 0033784614     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/00984100050166361     Document Type: Article

References (90)

1. Aksoy, M. 1988a. Benzene hematotoxicity. In Benzene carcinogenicity, ed. M. Aksoy, pp. 59-112. Boca Raton, FL: CRC Press.
2. Aksoy, M. 1988b. Benzene carcinogenicity. In Benzene carcinogenicity, ed. M. Aksoy, pp. 113-151. Boca Raton, FL: CRC Press.
3. 3H]benzene. Biochem. Pharmacol. 26: 293-300.
4. 3H-Benzene metabolism in rabbit bone marrow. Life Sci. 25:567-572.
5. Bainton, D. F., Ullyot, J. L., and Farquar, M. G. 1971. The development of neutrophilic polymorphonuclear l eukocytes in human bone marrow. J. Exp. Med. 134:907-934.
6. Baron, J. M., Zwaldo-Klarwasser, G., Jugert, F., Hamann, W., Rubben, A., Mukhtar, H., and Merk, H. F. 1998. Cytochrome P4501B1. A major P450 isoenzyme in human blood monocytes and macrophage subsets. Biochem. Pharmacol. 56:1105-1110.
7. Bleasedale, C., Cameron, R., Edwards, C., and Golding, B. T. 1997. Dimethyldioxirane converts benzene oxide/oxepin into (Z, Z)-muconaldehyde and sym-oxepin oxide: Modeling the metabolism of benzene and i ts photooxidative degradation. Chem. Res. Toxicol. 10:1314-1318.
8. Bratton, S. B., Lau, S. S., and Monks, T. J. 1997. Identification of quinol thioethers in bone marrow of hydroquinone/phenol-treated rats and mice and their potential role in benzene-mediated hematotoxicity. Chem. Res. Toxicol. 10:859-865.
9. Cadenas, E., Hochstein, P., and Ernster, L. 1992. Pro-and antioxidant functions of quinones and quinone reductases in mammalian cells. Adv. Enzymol. Relat. Areas Mol. Biol. 65:97-146.
10. Chaney, A. M., and Carlson, G. P. 1995. Comparison of rat hepatic and pulmonary microsomal metabolism of benzene and the lack of benzene induced pneumotoxicity and hepatotoxicity. Toxicology 104:53-62.
11. Chen, H. W., and Eastmond, D. A. 1995. Topoisomerase inhibition by phenolic metabolites: A potential mechanism f or benzene's clastogenic effects. Carcinogenesis 16:2301-2307.
12. Chertkov, J. L., Lutton, J. D., Jiang, S., Da Silva, J. L., and Abraham, N.G. 1992. Hematopoietic effects of benzene inhalation assessed by murine long term bone marrow culture. J. Lab. Clin. Med. 119:412-419.
13. De, P. K., and Bannerjee, R. K. 1992. Purification and characterization of a soluble peroxidase of rat preputial gland: Comparison with lactoperoxidase. Biochim. Biophys. Acta 1120:167-172.
14. Eastmond, D. A., Smith, M. T., and Irons, R. D. 1987. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol. Appl. Pharmacol. 91:85-95.
15. Eastmond, D. A., Rupa, D. S., and Hasegawa, L. S. 1994. Detection of hyperdiploidy and chromosome breakage in interphase human lymphocytes following exposure to the benzene metabolite hydroquinone using multicolor fluorescence in situ hybridization with DNA probes. Mutat. Res. Genet. Toxicol. Test. 322:9-20.
16. Fuchs, D., and v. Soos, A. 1916. Uber die Verbrennung des benzols in orgnaismus des menschen. Hoppe-Seylers Z. Physiol. Chem. 98:11-13.
17. Gad-El-Karim, M. M., Ramanujam, V. M., Ahmed, A. E., and Legator, M. S. 1985. Benzene myelo-clastogenicity: A function of its metabolism. Am. J. Ind. Med. 7:475-484.
18. Gad-El-Karim, M. M., Sadagopa Ramanujam, V. M., and Legator, M. S. 1986. Correlation between the induction of micronuclei in bone marrow by benzene exposure and the excretion of metabolites in urine of CD-1mice. Toxicol. Appl. Pharmacol. 85:464-477.
19. Gaido, K., and Wierda, D. 1984. In vitro effects of benzene metabolites in mouse bone marrow stromal cells. Toxicol. Appl. Pharmacol. 76:45-55.
20. Genter, M. B., and Recio, L. 1994. Absence of detectable P450 2E1in bone marrow of B6C3F1mice: Relevance to butadiene-induced bone marrow toxicity. Fundam. Appl. Toxicol. 22:469-473.
21. Goon, D., Cheng, X., Ruth, J. A., Petersen, D. R., and Ross, D. 1992. Metabolism of trans, trans-muconaldehyde by aldehyde and alcohol dehydrogenases: Identification of a novel metabolite. Toxicol. Appl. Pharmacol. 114:147-155.
22. Goon, D., Matsuura, J., and Ross, D. 1993. Metabolism and cytotoxicity of trans, trans-muconalde-hyde and its derivatives: Potential markers of benzene ring cleavage reactions. Chem. Biol. Interact. 88:37-53.
23. Gut, I., Nedelcheva, V., Soucek P., Stopka, P., Vodicka, P., Geboin, H. V., and Ingelman-Sundberg, M. 1996. The role of CYP2E1and 2B1in metabolic activation of benzene derivatives. Arch. Toxicol. 71:45-56.
24. Harrison, K., and Randoll, F. W. 1947. An application of bone marrow cultures to toxicology and therapeutics. J. Exp. Phys. 34:141-152.
25. Hedli, C. C., Hoffman, M. J., Thomas, P. E., and Snyder, R. 1997. Benzene metabolism in the isolated perfused mouse liver. Toxicol. Appl. Pharmacol. 146:60-68.
26. Irons, R. D., and Neptun, D. A. 1980. Effects of the principal hydroxy metabolites of benzene on microtubule polymerization. Arch. Toxicol. 45:297-305.
27. Johansson, I., and Ingelman-Sundberg, M. 1988. Benzene metabolism by ethanol-, acetone-, and benzene-inducible cytochrome P450IIE1in rat and rabbit liver microsomes. Cancer Res. 48: 5387-5390.
28. Joseph, P., Klein-Szanto, A. J. P., and Jaiswal, A. K. 1998. Hydroquinones cause specific mutations and lead to cellular transformation and in vivo tumorigenesis. Br. J. Cancer78:312-320.
29. Kline, S. A., Robertson, J. F., Grotz, V. L., Goldstein, B. D., and Witz, G. 1993. Identification of 6-hydroxy-trans, trans-2,4-hexadienoic acid, a novel ring-opened urinary metabolite of benzene. Environ. Health Perspect. 101:310-312.
30. Kolachana, P., Subrahmanyam, V. V., Meyer, K. B., Zhang, L., and Smith, M. T. 1993. Benzene and its phenolic metabolites produce oxidative DNA damage in HL-60 cells in vitro and in the bone marrow in vivo. Cancer Res. 53:1023-1026.
31. Koop, D. R., Laethem, C. L., and Schnier, G. G. 1989. Identification of ethanol inducible P450 isozyme 3a (P450IIE1) as a benzene and phenol hydroxylase. Toxicol. Appl. Pharmacol. 98: 278-288.
32. Krewet, E., Verkoyen, C., Müller, G., Schell, C., Popp, W., and Norpoth, K. 1993. Studies on guanine adducts excreted in rat urine after benzene exposure. Carcinogenesis 14:245-250.
33. Latriano, L., Goldstein, B. D., and Witz, G. 1986. Formation of muconaldehyde, an open ring metabolite of benzene, in mouse liver microsomes: An additional pathway of toxic metabolites. Proc. Natl. Acad. Sci. USA 83:8356-8360.
34. Lévay, G., and Bode11, W. J. 1992. Potentiation of DNA adduct formation in HL-60 cells by combinations of benzene metabolites. Proc. Natl. Acad. Sci. USA 89:7105-7109.
35. Li, Q., Aubrey, M. T., Christian, T., and Freed, B. M. 1997. Differential inhibition of DNA synthesis in human T cells by the cigarette tar components hydroquinone and catechol. Fundam. Appl. Toxicol. 38:158-165.
36. Li, Q., Kasten-Jolly, J., Yen, Y., and Freed, B. M. 1998. Reversal of hydroquinone-mediated suppression of T cell proliferation by transfection of the M2subunit of ribonucleotide reductase. Toxicol. Appl. Pharmacol. 150:154-157.
37. Li, Y., Kuppusamy, P., Zweier, J. L., and Trush, M. A. 1996. Role of Cu/Zn-superoxide dismutase in xenobiotic activation I. Chemical reactions involved in the Cu/Zn superoxide dismutase accelerated oxidation of the benzene metabolite 1,4-hydroquinone. Mol. Pharmacol. 49:404-411.
38. Lindstrom, A. B., Yeowell-O'Connell, K., Waidyanatha, S., Golding, B. T., Tornero-Velez, R., and Rappaport, S. M. 1997. Measurement of benzene oxide in the blood of rats following administration of benzene. Carcinogenesis 18:1637-1641.
39. Lovern, M. R., Turner, M. J., Meyer, M., Kedderis, G. L., Bechtold, W. E., and Schlosser, P. M. 1997. Identification of benzene oxide as a product of benzene metabolism by mouse, rat, and human liver microsomes. Carcinogenesis 18:1695-1700.
40. Low, L. K., Lambert, C. E., Meeks, J. R., Naro, P. A., and Mackerer, C. R. 1995. Tissue specific metabolism of benzene in Zymbal gland and other solid tumor target tissues in rats. J. Am. Coll. Toxicol. 14:40-60.
41. Lutton, J. D., Schwartzman, M. L., and Abraham, N. G. 1989. Cytochrome P450 dependent arachi-donic acid metabolism in hemopoietic cells. Adv. Exp. Med. Biol. 271:115-121.
42. Marrazzini, A., Chelloti, L., Barrai, I., Loprieno, N., and Barale, R. 1994. In vivo genotoxic interactions among three phenolic benzene metabolites. Mutat. Res. Genet. Toxicol. Test. 341:29-46.
43. McCord, A., Boyle, S. P., Knowler, J. T., Burnett, A. K., and Craft, J. A. 1996. Metabolism of benz(alpha)anthracene by human bone marrow in vitro. Chem. Biol. Interact. 99:29-40.
44. 6]benzene. Cancer Res. 54:4907-4914.
45. Meagher, R. C., Salvado, A. J., and Wright, D. G. 1988. An analysis of the multilineage production of human hematopoietic progenitors in long term bone marrow culture: Evidence that reactive oxygen intermediates derived from mature phagocytic cells have a role in limiting progenitor cell self renewal. Blood 72:273-281.
46. Medinsky, M. A., Kenton, E. M., and Schlosser, P. M. 1995. Benzene: A case study in parent chemical and metabolite interactions. Toxicology 105:225-233.
47. Morrison, V. M., Burnett, A. K., and Craft, J. A. 1991a. Metabolism of 7,12-dimethylbenz(a)-anthracene in hepatic microsomal membranes from rats treated with isoenzyme selective inducers of cytochromes P450. Biochem. Pharmacol. 41: 1505-1512.
48. Morrison, V. M., Burnett, A. K., Forrester, L. M., Wolf, C. R., and Craft, J. A. 1991b. The contribution of specific cytochromes P-450 in the metabolism of 7,12-dimethylbenzanthracene in rat and human liver microsomal membranes. Chem. Biol. Interact. 79:179-196.
49. Nakajima, T., Wang, R.-S., Elovarra, E., Park, S. S., Gelboin, H. V., and Vainio, H. 1992. A comparative study on the contribution of cytochrome P450 isozymes to metabolism of benzene, toluene and trichloroethylene in rat liver. Biochem. Pharmacol. 43:251-257.
50. O'Dowd, J. J. 1987. The metabolism in vitro of 7,12-dimethylbenz[a]anthracene by human bone marrow. Cancer Lett. 36:83-92.
51. 14C-benzene. Biochem. J. 54:231-238.
52. 14C-phenol. Biochem. J. 55:337-340.
53. Rappaport, S. M., McDonald, T. A., and Yeowell-O'Connell, K. 1996. The use of protein adducts to investigate the disposition of reactive metabolites of benzene. Environ. Health Perspect. Suppl. 104:1235-1237.
54. Rickert, D. E., Baker, T. S., Bus, J. S., Barrow, C. S., and Irons, R. D. 1979. Benzene disposition In the rat after exposure by inhalation. Toxicol. Appl. Pharmacol. 49:417-423.
55. Robertson, M. L., Eastmond, D. A., and Smith, M. T. 1991. Two benzene metabolites, catechol and hydroquinone, produce a synergistic induction of micronuclei and toxicity in cultured human lymphocytes. Mutat. Res. 249:201-209.
56. Ross, D. 1996. Metabolic basis of benzene toxicity. Eur. J. Haematol. 57(suppl. 60):111-118.
57. Ross, D., Siegel, D., Schattenberg D. G., and Moran, J. L. 1996. Cell-specific metabolism in benzene toxicity. A metabolic basis for benzene induced toxicity at the level of the progenitor cell in human bone marrow. Toxicologist 16:1740.
58. Rothman, N., Traver, R. D., Smith, M. T., Hayes, R. B., Li, G. L., Campleman, S., Dosemeci, M., Zhang, L., Linet, M., Wacholder, S., Yin, S. N., and Ross, D. 1997. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQ01C 609C to T mutation and fractional excretion of chlorzoxazone. Cancer Res. 57:2839-2842.
59. 3H-benzene by F344/N rats and B6C3F1mice. Toxicol. Appl. Pharmacol. 94:128-140.
60. Sammett, D., Lee, E. W., Kocsis, J. J., and Snyder, R. 1979. Partial hepatectomy reduces both metabolism and toxicity of benzene. J. Toxicol. Environ. Health 5:785-792.
61. Santesson, C. G. 1897. Uber chronische vergigtung mit steinkohlentheerbenzin vir todesfalle. Arch. Hyg. Berlin 31:336.
62. Schattenberg, D. G., Stillman, W. S., Gruntmeir, J. J., Helm, K. M., Irons, R. D., and Ross, D. 1994. Peroxidase activity in murine and human hematopoietic progenitor cells: Potential relevance to benzene-induced toxicity. Mol. Pharmacol. 46:346-351.
63. Schnier, G. G., Laethem, C. L., and Koop, D. R. 1989. Identification and induction of cytochromes P450, P450IIE1and P450IA1in rabbit bone marrow. J. Pharmacol. Exp. Ther. 251:790-796.
64. Selkirk, J. K., Croy, R. G., Whitlock, J. P., and Gelboin, H. V. 1975. In vitro metabolism of benzo(a)pyrene by human liver microsomes and l ymphocytes. Cancer Res. 35:3651-3655.
65. Siegel, D., Bolton, E. M., Burr, J. A., Liebler, D. C., and Ross, D. 1997. The reduction of alpha-toco-pherolquinone by human NAD(P)H: quinone oxidoreductase: The role of alpha-tocopherol hydroquinone as a cellular antioxidant. Mol. Pharmacol. 52:300-305.
66. Smith, M. T. 1996. The mechanism of benzene-induced leukemia: A hypothesis and speculations on the causes of leukemia. Environ. Health Perspect. Suppl. 104:1219-1225.
67. Smith, M. T., and Fanning, E. W. 1997. Report on the workshop entitled: "Modeling chemically induced l eukemia-Implications for benzene risk assessment." Leuk. Res. 21:361-374.
68. Snyder, R. 1984. The benzene problem in historical perspective. Toxicol. Appl. Pharmacol. 4:692-699.
69. Snyder, R., and Hedli, C. C. 1996. An overview of benzene metabolism. Environ. Health Perspect. Suppl. 104:1165-1171.
70. 5, microsomal epoxide hydrolase, and glutathione transferases: Evidence for an important role of microsomal epoxide hydrolase in the formation of hydroquinone. Toxicol. Appl. Pharmacol. 122:172-181.
71. Stillman, W. S., Varella-Garcia, M., Gruntmeir, J. J., and Irons, R. D. 1997. The benzene metabolite, hydroquinone, induces dose-dependent hypoploidy in a human cell line. Leukemia 11:1540-1545.
72. Strum, J. M., and Shear, C. R. 1982. Harderian glands in mice: Fluorescence, peroxidase activity and fine structure. Tissue Cell 14:135-148.
73. Subrahmanyam, V. V., Sadler, A., Suba, E., and Ross, D. 1989. Stimulation of the in vitro bioactivation of hydroquinone by phenol in bone marrow cells. Drug Metab. Dispos. 17:348-350.
74. Subrahmanyam, V. V., Doane-Setzer, P., Steinmetz, K. L., Ross, D., and Smith, M. T. 1990. Phenol-induced stimulation of hydroquinone bioactivation in mouse bone marrow in vivo: Possible implications in benzene myelotoxicity. Toxicology 62:107-116.
75. Thomas, D. J., Sadler, A., Subrahmanyam, V. V., Siegel, D., Reasor, M. J., Wierda, D., and Ross, D. 1990. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: Comparison of macrophages and fibroblastoid cells. Mol. Pharmacol. 37:255-262.
76. Traver, R. D., Siegel, D., Beall, H. D., Phillips, R. M., Gibson, N. W., Franklin, W.A., and Ross, D. 1997. Characterization of a polymorphism in NAD(P)H: Quinone oxidoreductase (DT-diaphor-ase). Br. J. Cancer 75:69-75.
77. Tunek, A., Platt, K., Bentley, P., and Oesch, F. 1978. Microsomal metabolism of benzene to species irreversibly binding to microsomal protein and effects of modifications of this metabolism. Mol. Pharmacol. 14:920-929.
78. Tunek, A., Olofsson, T., and Berlin, M. 1981. Toxic effects of benzene and benzene metabolites on granulopoietic stem cells and bone marrow cellularity in mice. Toxicol. Appl. Pharmacol. 59: 149-156.
79. Tuo, J., Loft, S., Thomsen, M. S., and Poulsen, H. E. 1996. Benzene induced genotoxicity in mice invivo detected by the alkaline comet assay; Reduction by CYP2E1inhibition. Mutat. Res. 368: 213-219.
80. Twerdok, L. E., and Trush, M. A. 1990. Differences in quinone reductase activity in primary bone marrow stromal cells derived from C57Bl/6 and DBA/2mice. Res. Commun. Chem. Path. Physiol. 67:375-386.
81. Twerdok, L. E., Rembish, S. J., and Trush, M. A. 1992. Induction of quinone reductase and glutathione in bone marrow cells by 1,2-dithiole-3-thione. Effect on hydroquinone-induced cytotoxicity. Toxicol. Appl. Pharmacol. 112:273-281.
82. Twerdok, L. E., Rembish, S. J., and Trush, M. A. 1993. Studies with 1,2-dithiole-3-thione as a chemo-protector of hydroquinone-induced toxicity to DBA/2-derived bone marrow stromal cells. Environ. Health Perspect. 101:172-177.
83. Valentine, J. L., Lee, S. S. T., Seaton, M. J., Asgharian, B., Farris, G., Corton, J. C., Gonzalez, F. J., and Medinsky, M. A. 1996. Reduction of benzene metabolism and toxicity in mice that lack CYP2E1expression. Toxicol. Appl. Pharmacol. 141:205-213.
84. Witz, G., Rao, G. S., and Goldstein, B. D. 1985. Short term toxicity of trans, trans-muconaldehyde. Toxicol. Appl. Pharmacol. 80:511-516.
85. Witz, G., Zhang, Z., and Goldstein, B. D. 1996. Reactive ring opened aldehyde metabolites in benzene hematotoxicity. Environ. Health Perspect. Suppl. 104:1195-1199.
86. Yeowell-O'Connell, K., Rothman, N., Smith, M. T., Hayes, R. B., Li, G., Waidyanatha, S., Dosemeci, M., Zhang, L., Yin, S., Titenko-Holland, N., and Rappaport, S. M. 1998. Hemoglobin and albumin adducts of benzene oxide among workers exposed to high levels of benzene. Carcinogenesis 19:1565-1571.
87. Zakhireh, B., and Root, R. K. 1979. Development of oxidase activity by human bone marrow granulocytes. Blood 54:429-439.
88. Zhang, L. P., Wang, Y. X., Shang, N., and Smith, M. T. 1998. Benzene metabolites induce the loss and long arm deletion of chromosomes 5 and 7 in human lymphocytes. Leuk. Res. 22:105-113.
89. Zhang, Z., Schafer, F., Schoenfeld, H., Cooper, K., Snyder, R., Goldstein, B. D., and Witz, G. 1995. The hematotoxic effects of 6-hydroxy-trans, trans-2,4-hexadienal, a reactive metabolite of trans, trans-muconaldehyde, in CD-1mice. Toxicol. Appl. Pharmacol. 132:213-219.
90. 14C]muconaldehyde. Arch. Toxicol. 71:703-708.